CoChat

Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact

Open access
Oepkes, Dick, Page‐Christiaens, G. C. (Lieve), Bax, Caroline J., Bekker, Mireille N., Bilardo, Catia M., Boon, Elles M. J., Schuring‐Blom, G. Heleen, Coumans, Audrey B. C., Faas, Brigitte H., Galjaard, Robert‐Jan H., Go, Attie T., Henneman, Lidewij, Macville, Merryn V. E., Pajkrt, Eva, Suijkerbuijk, Ron F., Huijsdens‐van Amsterdam, Karin, Van Opstal, Diane, Verweij, E. J. (Joanne), Weiss, Marjan M., Sistermans, Erik A., and for the Dutch NIPT Consortium · 2016 · Prenatal Diagnosis
Cited by 149

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To evaluate the clinical impact of nationwide implementation of genome-wide non-invasive prenatal testing (NIPT) in pregnancies at increased risk for fetal trisomies 21, 18 and 13 (TRIDENT study). METHOD: Women with elevated risk based on first trimester combined testing (FCT ≥ 1:200) or medical history, not advanced maternal age alone, were offered NIPT as contingent screening test, performed by Dutch University Medical laboratories. We analyzed uptake, test performance, redraw/failure rate, turn-around time and pregnancy outcome. RESULTS: Between 1 April and 1 September 2014, 1413/23 232 (6%) women received a high-risk FCT result. Of these, 1211 (85.7%) chose NIPT. One hundred seventy-nine women had NIPT based on medical history. In total, 1386/1390 (99.7%) women received a result, 6 (0.4%) after redraw. Mean turn-around time was 14 days. Follow-up was available in 1376 (99.0%) pregnancies. NIPT correctly predicted 37/38 (97.4%) trisomies 21, 18 or 13 (29/30, 4/4 and 4/4 respectively); 5/1376 (0.4%) cases proved to be false positives: trisomies 21 (n = 2), 18 (n = 1) and 13 (n = 2). Estimated reduction in invasive testing was 62%. CONCLUSION: Introduction of NIPT in the Dutch National healthcare-funded Prenatal Screening Program resulted in high uptake and a vast reduction of invasive testing. Our study supports offering NIPT to pregnant women at increased risk for fetal trisomy. © 2016 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd. © 2016 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pd.4945

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 149

Metadata

Authors
Oepkes, D., Page‐Christiaens, G. C. (., Bax, C. J., Bekker, M. N., Bilardo, C. M., Boon, E. M. J., Schuring‐Blom, G. H., Coumans, A. B. C., Faas, B. H., Galjaard, R. H., Go, A. T., Henneman, L., Macville, M. V. E., Pajkrt, E., Suijkerbuijk, R. F., Huijsdens‐van Amsterdam, K., Van Opstal, D., Verweij, E. J. (., Weiss, M. M., Sistermans, E. A., & and for the Dutch NIPT Consortium
Venue
Prenatal Diagnosis
Publisher
Wiley
Published
2016-11-15
Volume
36
Issue
12
Pages
1083-1090
ISSN
  • 0197-3851 (ISSN-L)
  • 1097-0223
OpenAlex
W2538950255
Cited by
149
References
2
FWCI
21.67
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact. https://app.cochat.ai/papers/10.1002/pd.4945
The paper
Oepkes, D., Page‐Christiaens, G. C. (., Bax, C. J., Bekker, M. N., Bilardo, C. M., Boon, E. M. J., Schuring‐Blom, G. H., Coumans, A. B. C., Faas, B. H., Galjaard, R. H., Go, A. T., Henneman, L., Macville, M. V. E., Pajkrt, E., Suijkerbuijk, R. F., Huijsdens‐van Amsterdam, K., Van Opstal, D., Verweij, E. J. (., Weiss, M. M., . . . and for the Dutch NIPT Consortium. (2016). Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact. Prenatal Diagnosis. https://doi.org/10.1002/pd.4945

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.